OMass Therapeutics funding
OMass Therapeutics is a biotech company developing small molecule therapeutics. Headquarters: Oxford, United Kingdom.
Funding rounds
- OMass Therapeutics raises $295M Series C, . Other. Led by Bain Capital Life Sciences, Forbion, Novo Holdings. OMass Therapeutics is a biotech company developing small molecule therapeutics.
Questions
How much has OMass Therapeutics raised?
OMass Therapeutics has raised $295M in the 1 round Funding tracks, most recently a Series C announced Oct 16, 2026.
What is OMass Therapeutics's valuation?
No valuation has been reported for OMass Therapeutics's tracked rounds.
Who invests in OMass Therapeutics?
Bain Capital Life Sciences, Forbion, Novo Holdings, Janus Henderson Investors, SV Health Investors, Jefferson Life Sciences.